Articles by Lynn D. Torbeck - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Lynn D. Torbeck

Compositing Samples and the Risk to Product Quality

Compositing samples is appropriate under certain circumstances but raises caveats on how and when it should be applied.
May 2, 2013

Compositing samples is appropriate under certain circumstances but raises caveats on how and when it should be applied.

Time to Revise ICH Q9

A change in terminology could emphasize patient protection.
Dec 2, 2012

A change in terminology could emphasize patient protection.

Tools in Waiting: Time for Evolutionary Operation

Real-time experimentation may offer continuous process improvement.
Oct 2, 2012

Real-time experimentation may offer continuous process improvement.

A Statistical Review of ICH Q10 Pharmaceutical Quality System

Applying the recommendations of ICH Q10 to statistical analysis can help prevent product recalls.
Aug 2, 2012

Applying the recommendations of ICH Q10 to statistical analysis can help prevent product recalls.

Placket–Burman Designs

Applying current principals to traditional factorial designs.
Jul 2, 2012

Applying current principals to traditional factorial designs.

Representative Sampling

Understanding the differences between convenience, target, and self-selected samples.
Apr 2, 2012

Understanding the differences between convenience, target, and self-selected samples.

Reducing Common Cause Variation

Where is the variability coming from and what have we done to minimize it?
Feb 2, 2012

Where is the variability coming from and what have we done to minimize it?

Out-of-Specification Sample-Size Confusion

Precedents set in the historic Barr case continue to raise questions over suitable sample-size criteria.
Dec 2, 2011

Precedents set in the historic Barr case continue to raise questions over suitable sample-size criteria.

OOS, OOT, OOC, and OOSC

Current GMPs demand full understandng of out-of-control concepts. This article contains bonus material.
Oct 2, 2011

Current GMPs demand full understandng of out-of-control concepts. This article contains bonus material.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here